Jardiance Met Tablet (Empagliflozin Metformin) | Synjardy | Used to Treat Type 2 Diabetes Mellitus in Adults
Jardiance Met Tablet is used to manage blood sugar levels in adults with type 2 diabetes mellitus by improving insulin sensitivity and removing excess glucose through urine. It is also known by the brand name Synjardy, is a combination medication containing Empagliflozin and Metformin.
Product Overview
Jardiance Met is a medication designed to assist in the management of blood sugar levels for adults with type 2 diabetes. It combines two effective antidiabetic agents—Empagliflozin and Metformin—in a single oral tablet. By combining two effective glucose-lowering agents, this dual-action tablet helps provide comprehensive glycemic control when diet and exercise alone are not sufficient. It is widely recognized for its efficiency in lowering HbA1c levels and reduce cardiovascular death risk in adults with known heart disease, and manage kidney disease.
Product Composition
This medication features a synergistic blend of two primary active ingredients:
- Empagliflozin: A potent SGLT2 (sodium-glucose co-transporter 2) inhibitor that works with the kidneys.
- Metformin Hydrochloride: A well-established biguanide that improves insulin sensitivity and reduces glucose production in the liver.
Product Specification
| Feature | Details |
| Therapeutic Class | Oral Antidiabetic Combination |
| Dosage Form | Film-Coated Tablet |
| Primary Indications | Type 2 Diabetes Mellitus Management |
| Storage Requirements | Store at room temperature away from moisture |
| Common Strengths | 5mg/500mg, 12.5mg/500mg, 12.5mg/1000mg |
Mechanism of Action
Jardiance Met employs a multi-pathway approach to stabilize blood sugar levels through its dual-component system:
- Glucose Elimination: The Empagliflozin component targets the kidneys to block the reabsorption of glucose back into the bloodstream. Instead, excess sugar is eliminated from the body through urine.
- Hepatic Regulation: Metformin reduces the amount of glucose produced by the liver, which is a common cause of high fasting blood sugar levels.
- Insulin Sensitivity: It enhances the body’s natural response to insulin, allowing cells to utilize existing blood sugar more effectively for energy.
- Intestinal Absorption: The formula slows down the absorption of sugar in the intestines after meals, preventing sharp glucose spikes.
Key Benefits
- Superior Glycemic Control: The combination therapy often leads to a more significant reduction in HbA1c levels compared to using either medication individually.
- Cardiovascular Protection: Studies have shown that the SGLT2 inhibitor component can reduce the risk of cardiovascular death in adults with type 2 diabetes and established heart disease.
- Weight Management Support: Many users experience modest weight loss as a secondary benefit due to the calorie loss associated with glucose excretion.
- Blood Pressure Regulation: The mild diuretic effect of the medication can contribute to a slight reduction in systolic blood pressure.
- Convenience: Combining two medications into a single tablet simplifies the daily treatment regimen, leading to better patient compliance.
Usage
The effective use of Jardiance Met depends on consistent timing and adherence to professional medical advice to ensure maximum efficacy and safety.
Dosage
The dosage is highly individualized based on the patient's current medical regimen, blood sugar levels, and renal function. It is typically available in multiple strengths to allow for precise titration.
| Aspect | Recommendation |
| Standard Frequency | Usually taken twice daily |
| Missed Dose | Take as soon as remembered; do not double the dose |
| Maximum Dose | Should not exceed the specific daily limit prescribed by a doctor |
Administration
With Meals: This medication should be taken with food. Administering it during a meal helps significantly reduce the risk of stomach upset or gastrointestinal discomfort common with Metformin.
Whole Consumption: Tablets must be swallowed whole with a full glass of water. They should not be crushed, chewed, or broken, as this can interfere with the intended release of the medication.
Consistent Schedule: For the best results in stabilizing glucose, take the doses at the same time each morning and evening.
Hydration: It is important to maintain adequate fluid intake while using this medication to support the kidneys in the glucose elimination process.
Uses
Jardiance Met is a high-performance prescription treatment specifically formulated to manage blood sugar levels and protect long-term health in adults.
Glycemic Control for Type 2 Diabetes: It is primarily used to lower blood sugar in adults with type 2 diabetes, especially when diet, exercise, and single-agent medications are insufficient.
Cardiovascular Risk Reduction: This combination therapy is indicated to reduce the risk of cardiovascular death in adults who have both type 2 diabetes and established heart disease.
Stabilizing HbA1c Levels: It works through multiple pathways to help patients reach their target blood sugar markers and maintain steady glucose throughout the day.
Prevention of Diabetes Complications: By consistently managing blood sugar, it helps lower the risk of developing serious associated conditions such as kidney disease and nerve damage.
Side Effects
Jardiance Met Tablet (Empagliflozin and Metformin) may cause side effects, ranging from mild to serious. Most are manageable, but serious reactions require immediate medical attention.
Common Side Effects
- Increased urination
- Urinary tract infections
- Genital fungal infections
- Nausea or vomiting
- Diarrhea
- Abdominal discomfort
- Headache
- Increased thirst
Less Common Side Effects
- Dizziness or light-headedness
- Fatigue or weakness
- Mild skin rash or itching
- Low blood pressure, especially on standing
- Weight loss
Serious Side Effects
| Serious Condition | Symptoms |
|---|---|
| Lactic acidosis | Severe weakness, muscle pain, difficulty breathing, unusual sleepiness |
| Ketoacidosis | Nausea, vomiting, stomach pain, rapid breathing, confusion |
| Severe dehydration | Very low urine output, extreme thirst, dizziness, confusion |
| Severe urinary tract infection | Fever, pain during urination, lower abdominal or back pain |
| Allergic reaction | Swelling of face, lips, tongue, or throat, severe rash, breathing difficulty |
Important Advice
- Maintain proper hydration during treatment
- Monitor blood sugar levels regularly
- Seek immediate medical help if any serious symptoms occur
Interactions
Jardiance Met Tablet (Empagliflozin and Metformin) may interact with various medicines, which can affect blood sugar control, kidney function, or increase the risk of side effects.
Antidiabetic Medicines
| Medicine Class | Interaction Effect |
|---|---|
| Insulin | Increased risk of hypoglycemia (low blood sugar) |
| Sulfonylureas (e.g., glimepiride, gliclazide) | Higher chance of excessive blood sugar lowering |
| Other SGLT2 inhibitors | Not recommended due to additive glucose-lowering effects |
| Other Metformin-containing medicines | Increased risk of overdose and lactic acidosis |
Blood Pressure and Heart Medications
- Diuretics (water pills) may increase risk of dehydration and low blood pressure
- ACE inhibitors and ARBs require monitoring for kidney function changes
- Beta-blockers may mask symptoms of low blood sugar
Contrast Media and Imaging Agents
- Iodinated contrast agents may increase risk of kidney damage and lactic acidosis
- Temporary discontinuation of the medicine may be required before imaging tests
Alcohol
- Can increase risk of lactic acidosis with Metformin
- May cause unpredictable blood sugar fluctuations
- Should be avoided or strictly limited
Other Medicines
- Corticosteroids may raise blood sugar levels and reduce effectiveness
- Thyroid medications may affect glucose metabolism
- Antipsychotic drugs may interfere with blood sugar control
General Advice
- Always inform your doctor about all prescription, OTC, and herbal medicines you are using
- Regular monitoring of blood glucose and kidney function is recommended during treatment
| Manufacturer | : | Boehringer Ingelheim |
| Trade Name | : | Synjardy |
| Generic Search | : | Empagliflozin+ Metformin |
| Strength | : | 12.5mg + 1000mg, 5mg + 500 mg, 12.5mg + 500mg |
Latest Products
